Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Dirk J GrünhagenA M Eggermont

Abstract

The treatment of melanoma in-transit metastases (IT-mets) can vary widely and is dependant on the size and the number of the lesions. When multiple, large lesions exist, isolated limb perfusion (ILP) has established itself as an attractive treatment option with high response rates. Review on the various methods of treatment of melanoma in-transit metastases, with a focus on isolated limb perfusion. A Medline based literature search was performed for articles relating to this topic. Additional original papers were obtained from citations in those identified by the initial search. Indications and results are discussed and the extra value of tumour necrosis factor (TNF) is evaluated. ILP with Melphalan results in complete response rates of 40-82% and showed to be 54% in a large retrospective meta-analysis. The addition of TNF can improve these completes response rates (59-85%) and although no data from randomized controlled trials are available, it seems of particular value in large, bulky lesions or in patients with recurrent disease after previous ILP. TNF-based ILP has earned a permanent place in the treatment of patients with melanoma IT-mets. In patients with a high tumour burden, TNF-based ILP is the most efficacious procedu...Continue Reading

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Jun 1, 1992·American Journal of Clinical Oncology·E R FeldmanD L Ahmann
Apr 1, 1990·Journal of Surgical Oncology·A CalabroS S Legha
Nov 15, 1986·International Journal of Cancer. Journal International Du Cancer·P G BrouckaertW Fiers
Feb 15, 1987·International Journal of Cancer. Journal International Du Cancer·U RegenassA Matter
Oct 1, 1982·European Journal of Cancer & Clinical Oncology·J WieberdinkG A Olthuis
May 1, 1995·World Journal of Surgery·P J BryantW S Egerton
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F J Lejeune
Sep 1, 1994·Journal of Cellular Biochemistry·F LejeuneP Schmitz
Aug 1, 1993·The British Journal of Surgery·S HillJ M Thomas
Sep 1, 1993·The British Journal of Surgery·J M KlaaseH R Franklin
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F J LejeuneR O Mirimanoff
Apr 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E R ManusamaA M Eggermont
Apr 1, 1996·The British Journal of Surgery·S Hill, J M Thomas
Oct 1, 1996·The British Journal of Surgery·B C VrouenraetsB B Kroon
Sep 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M K LingamA J McKay
Aug 1, 1997·Archives of Surgery·J F ThompsonP C Kam
Dec 11, 1997·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L J StrobbeB B Kroon
Apr 21, 1998·Seminars in Surgical Oncology·J F ThompsonC R Harman
Apr 13, 1999·American Journal of Clinical Oncology·E FenigJ Schechter
Nov 30, 2000·Melanoma Research·M P RolsJ Teissié

❮ Previous
Next ❯

Citations

Nov 15, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P RehbergerJ Schmitt
Feb 3, 2011·Irish Journal of Medical Science·L RomicsH P Redmond
Oct 11, 2011·Molecular Pharmaceutics·Jonathan W WojtkowiakRobert J Gillies
May 30, 2008·Annals of Surgical Oncology·Hidde M KroonJohn F Thompson
May 24, 2008·Annals of Surgical Oncology·P QuaglinoM G Bernengo
Apr 2, 2014·World Journal of Surgical Oncology·Lars Erik PodleskaGeorg Taeger
Feb 5, 2015·Current Medical Research and Opinion·Hervé LebrecMichele Hooper
Nov 21, 2007·Surgical Oncology Clinics of North America·Nicole M AgostinoPaul J Mosca
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georgia M BeasleyDouglas S Tyler
Oct 15, 2008·São Paulo Medical Journal = Revista Paulista De Medicina·Sergio Renato Pais CostaAlexandre Cruz Henriques
Dec 1, 2006·Expert Review of Anticancer Therapy·Adam I RikerC Wayne Cruse
Jan 1, 2010·Cancers·Piotr RutkowskiAlexander C J Van Akkooi
Oct 1, 2008·British Journal of Cancer·C H Ottensmeier, M Gore
Apr 15, 2009·Journal of Surgical Oncology·Hidde M Kroon, John F Thompson
Apr 9, 2008·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·G M BeasleyD S Tyler
Aug 4, 2011·Bioelectromagnetics·Marie Breton, Lluis M Mir
Oct 13, 2012·Melanoma Research·Nora J SuojärviMicaela M Hernberg
Dec 21, 2019·Current Oncology Reports·Alessandro A E TestoriAlexander C J van Akkooi
Nov 7, 2019·Current Oncology Reports·Alessandro A E TestoriAlexander C J van Akkooi
Sep 21, 2019·Future Oncology·John T Miura, Jonathan S Zager
Sep 25, 2012·ANZ Journal of Surgery·João Pedreira Duprat NetoJosé H Fregnani
May 26, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·N SolariF Cafiero
Aug 25, 2020·Revista española de medicina nuclear e imagen molecular·A Agudo MartínezJ Castro Montaño
Oct 13, 2006·Annales de chirurgie plastique et esthétique·A LavieG Magalon
Aug 25, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Dingyuan MaZichun Hua
May 10, 2011·Current Problems in Surgery·Amira SankiJohn F Thompson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.